These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20674353)

  • 1. Development of methotrexate proline prodrug to overcome resistance by MDA-MB-231 cells.
    Wu Z; Shah A; Patel N; Yuan X
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5108-12. PubMed ID: 20674353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptide.
    Lindgren M; Rosenthal-Aizman K; Saar K; Eiríksdóttir E; Jiang Y; Sassian M; Ostlund P; Hällbrink M; Langel U
    Biochem Pharmacol; 2006 Feb; 71(4):416-25. PubMed ID: 16376307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolidase, a potential enzyme target for melanoma: design of proline-containing dipeptide-like prodrugs.
    Mittal S; Song X; Vig BS; Landowski CP; Kim I; Hilfinger JM; Amidon GL
    Mol Pharm; 2005; 2(1):37-46. PubMed ID: 15804176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proline analogue of melphalan as a prodrug susceptible to the action of prolidase in breast cancer MDA-MB 231 cells.
    Chrzanowski K; Bielawska A; Pałka J
    Farmaco; 2003 Nov; 58(11):1113-9. PubMed ID: 14572862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Das JR; Fryar-Tita EB; Zhou Y; Green S; Southerland WM; Bowen D
    Anticancer Res; 2007; 27(6B):3791-9. PubMed ID: 18225534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.
    Bowen D; Southerland WM; Johnson DH; Hawkins M; Hughes DE
    Cancer Detect Prev; 2000; 24(5):452-8. PubMed ID: 11129987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased cytotoxicity and increased antimitotic activity of a proline analogue of chlorambucil as a prodrug susceptible to the action of fibroblast's prolidase.
    Bielawska A; Chrzanowski K; Bielawski K; Pałka J
    Pharmazie; 2001 Apr; 56(4):290-4. PubMed ID: 11338665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Fluorouracil simultaneously maintains methotrexate antineoplastic activity in human breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Bowen D; Johnson DH; Southerland WM; Hughes DE; Hawkins M
    Anticancer Res; 1999; 19(2A):985-8. PubMed ID: 10368642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone.
    Weigand M; Hartung G; Roboz J; Sieger S; Wolf M; Sinn H; Schrenk HH; Wiessler M; Frei E
    Anticancer Drug Des; 2001; 16(4-5):227-37. PubMed ID: 12049481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of differentially expressed proteins associated with the multiple drug resistance in methotrexate-resistant human breast cancer cells.
    Chen S; Cai J; Zhang W; Zheng X; Hu S; Lu J; Xing J; Dong Y
    Int J Oncol; 2014 Jul; 45(1):448-58. PubMed ID: 24736981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Chen G; Wright JE; Rosowsky A
    Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell surface tethered enzyme improves efficiency in gene-directed enzyme prodrug therapy.
    Marais R; Spooner RA; Stribbling SM; Light Y; Martin J; Springer CJ
    Nat Biotechnol; 1997 Dec; 15(13):1373-7. PubMed ID: 9415889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential subcellular distribution of mitoxantrone in relation to chemosensitization in two human breast cancer cell lines.
    Vibet S; Mahéo K; Goré J; Dubois P; Bougnoux P; Chourpa I
    Drug Metab Dispos; 2007 May; 35(5):822-8. PubMed ID: 17296624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of growth and cancer-induced angiogenesis of aggressive human breast cancer cells (MDA-MB-231) on the chorioallantoic membrane of developing chicken embryos by E-peptide of pro-IGF-I.
    Chen MJ; Chiou PP; Lin P; Lin CM; Siri S; Peck K; Chen TT
    J Cell Biochem; 2007 Aug; 101(5):1316-27. PubMed ID: 17286280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary study on establishment of namalwa 12/MTX resistant cell strain and its mechanism].
    Chen J; Gu LJ; Ying DM; Shen M; Wu HJ
    Ai Zheng; 2002 Dec; 21(12):1335-40. PubMed ID: 12520743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of human erythroleukemia K562 cells resistant to methotrexate by inhibiting IMPDH.
    Peñuelas S; Noé V; Morales R; Ciudad CJ
    Med Sci Monit; 2005 Jan; 11(1):BR6-12. PubMed ID: 15614187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alkaloid Berberine inhibits the growth of Anoikis-resistant MCF-7 and MDA-MB-231 breast cancer cell lines by inducing cell cycle arrest.
    Kim JB; Yu JH; Ko E; Lee KW; Song AK; Park SY; Shin I; Han W; Noh DY
    Phytomedicine; 2010 May; 17(6):436-40. PubMed ID: 19800775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
    Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
    Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cells.
    De Soto JA; Bowen D; Davis JH; Southerland WM; Hawkins M
    Anticancer Res; 2002; 22(2A):1007-9. PubMed ID: 12014617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.